A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes (NCT07215559)
A Phase 2, Parallel-Group, Double-Blind, Placebo-Controlled Study to Investigate Weight Reduction With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight and With Type 2 Diabetes
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to investigate weight reduction with macupatide and eloralintide, alone or in combination, in adult participants with obesity or overweight and with type 2 diabetes. Participation in the study will last about 48 weeks.
Who can join: Review the eligibility criteria below.
Location: Prime Medical Group, LLC dba Gilbert Center for Family Medicine, LLC — Gilbert, Arizona
Age range: 18 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (42 Sites)
Showing the first 25 of 42 sites.
- Prime Medical Group, LLC dba Gilbert Center for Family Medicine, LLC — Gilbert, Arizona
- Synexus Clinical Research US, Inc. — Phoenix, Arizona
- Pima Heart — Tucson, Arizona
- Precision Clinical Research — Sunrise, Florida
- SKY Clinical Research Network Group-Brown — Atlanta, Georgia
- Teak Research Consults — Lawrenceville, Georgia
- AGILE Clinical Research Trials, LLC — Sandy Springs, Georgia
- Pivotal Research Solutions — Stonecrest, Georgia
- Rophe Adult and Pediatric Medicine/SKYCRNG — Union City, Georgia
- Vector Clinical Trials — Las Vegas, Nevada
- Premier Research — Trenton, New Jersey
- PriMED Clinical Research — Dayton, Ohio
- Mercy Family Clinic — Dallas, Texas
- Velocity Clinical Research, Dallas — Dallas, Texas
- Biopharma Informatic, LLC — Houston, Texas
- PlanIt Research, PLLC — Houston, Texas
- Research Physicians Network, LLC — Houston, Texas
- Aavon Clinical Trials — Richmond, Texas
- Consano Clinical Research, LLC — Shavano Park, Texas
- Texas Valley Clinical Research — Weslaco, Texas
- Kalo Clinical Research — West Valley City, Utah
- Eastern Virginia Medical School (EVMS) Medical Group — Norfolk, Virginia
- Clinical Research Partners, LLC — Richmond, Virginia
- Northwest Clinical Research Center — Bellevue, Washington
- Rainier Clinical Research Center — Renton, Washington
📞 Contact the Study Coordinator
Phone: (317) 615-4559
Email: LillyTrials@Lilly.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Obesity
- Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Tools — Tampa, Florida
- SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity — Tucson, Arizona
- Piloting a Patient Navigator Program for Weight Loss — Philadelphia, Pennsylvania
- Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide in Participants With Obesity (RESOLVE-2) — Mesa, Arizona
- Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects — Orlando, Florida
- Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans — Pittsburgh, Pennsylvania
Explore by condition: All Obesity clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.